Hyperlipidemia in children with chronic renal insufficiency

Area of Science:

• Pediatric Nephrology
• Clinical Biochemistry
• Lipid Metabolism

Background:

• Children with chronic kidney disease (CKD) and those undergoing hemodialysis often exhibit altered lipid profiles.
• Understanding these changes is crucial for managing cardiovascular risk in this population.

Purpose of the Study:

• To investigate serum lipid profiles, including total cholesterol, phospholipids, triglycerides, and lipoprotein fractions, in nonnephrotic children with varying degrees of renal function and on hemodialysis.
• To assess plasma parathormone levels in relation to renal function and lipid abnormalities.

Main Methods:

• Cross-sectional study involving 31 nonnephrotic children categorized into four groups based on glomerular filtration rate (GFR) and dialysis status.
• Measurements included total serum cholesterol, phospholipids, triglycerides, lipoprotein fractionation (pre-beta, beta, alpha lipoproteins), and plasma parathormone levels.
• Statistical analysis was performed to compare parameters across the different study groups.

Main Results:

• No significant differences in total serum cholesterol and phospholipid levels were found across groups.
• Triglyceride levels were significantly increased in children with GFR < 40 ml/min/1.73 m2 and those on hemodialysis (P < 0.05).
• A significant increase in very-low-density lipoproteins (pre-beta) and a significant decrease in high-density lipoproteins (alpha) were observed in children with GFR < 40 ml/min/1.73 m2 and those on hemodialysis (P < 0.05).
• Plasma parathormone levels increased significantly after the onset of hemodialysis.

Conclusions:

• Children with advanced CKD and those on hemodialysis exhibit dyslipidemia characterized by elevated triglycerides and reduced HDL.
• These lipid alterations, particularly the increase in VLDL and decrease in HDL, are associated with impaired renal function and hemodialysis.
• Further research is needed to explore the clinical implications and management strategies for dyslipidemia in pediatric kidney disease.